Refractory myelomatosis treated with mitoxantrone in combination with vincristine and prednisone (NOP-regimen): a phase II study. The Nordic Myeloma Study Group (NMSG)

P Gimsing; O W Bjerrum; E Brandt; J Ellegaard; S A Evensen; M M Hansen; M Hedenus; E Hippe; N Keldsen; I Palva

doi:10.1111/j.1365-2141.1991.tb07951.x

Refractory myelomatosis treated with mitoxantrone in combination with vincristine and prednisone (NOP-regimen): a phase II study. The Nordic Myeloma Study Group (NMSG)

Identifier:nobleid.org/w1/20260515/BA49AB56

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/BA49AB56.svg?ark=w1%2F20260515%2FBA49AB56)](https://nobleid.org/work/w1/20260515/BA49AB56)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Refractory myelomatosis treated with mitoxantrone in combination with vincristine and prednisone (NOP-regimen): a phase II study. The Nordic Myeloma Study Group (NMSG)

Identifier:nobleid.org/w1/20260515/BA49AB56

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/BA49AB56.svg?ark=w1%2F20260515%2FBA49AB56)](https://nobleid.org/work/w1/20260515/BA49AB56)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work